2nd Quarter - Report
SENIOR CARE PHARMACY COALITION for SENIOR CARE PHARMACY COALITION
Income
—
Expenses
$320,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices. H.R. 5031 / S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ESME GRANT GREWAL New | — |
| SHARA SIEGEL | Food and Drug Administration, Public Health Advisor (March 2024-June 2025) |
Health Issues HCR
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices. H.R. 5031 / S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ESME GRANT GREWAL New | — |
| SHARA SIEGEL | Food and Drug Administration, Public Health Advisor (March 2024-June 2025) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.